Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Clinical trial NCT02107807 · COMPLETED

Trial details

NCT number: NCT02107807
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza, Human Flu, Human Flu, Avian Influenza Influenza A Virus, H5N1 Subtype

Start date: 2014-04-01
Primary completion: 2015-05-01
Enrollment: 539

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.